Global Rectal Cancer Therapeutics Market Research Report 2023

Report ID: 1878717 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rectal Cancer Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Medicine
        1.2.3 Surgery
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Rectal Cancer Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Rectal Cancer Therapeutics Market Perspective (2017-2028)
    2.2 Rectal Cancer Therapeutics Growth Trends by Region
        2.2.1 Rectal Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Rectal Cancer Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Rectal Cancer Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Rectal Cancer Therapeutics Market Dynamics
        2.3.1 Rectal Cancer Therapeutics Industry Trends
        2.3.2 Rectal Cancer Therapeutics Market Drivers
        2.3.3 Rectal Cancer Therapeutics Market Challenges
        2.3.4 Rectal Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Rectal Cancer Therapeutics Players by Revenue
        3.1.1 Global Top Rectal Cancer Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Rectal Cancer Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Rectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Rectal Cancer Therapeutics Revenue
    3.4 Global Rectal Cancer Therapeutics Market Concentration Ratio
        3.4.1 Global Rectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rectal Cancer Therapeutics Revenue in 2021
    3.5 Rectal Cancer Therapeutics Key Players Head office and Area Served
    3.6 Key Players Rectal Cancer Therapeutics Product Solution and Service
    3.7 Date of Enter into Rectal Cancer Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Rectal Cancer Therapeutics Breakdown Data by Type
    4.1 Global Rectal Cancer Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Rectal Cancer Therapeutics Forecasted Market Size by Type (2023-2028)
5 Rectal Cancer Therapeutics Breakdown Data by Application
    5.1 Global Rectal Cancer Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Rectal Cancer Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Rectal Cancer Therapeutics Market Size (2017-2028)
    6.2 North America Rectal Cancer Therapeutics Market Size by Country (2017-2022)
    6.3 North America Rectal Cancer Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Rectal Cancer Therapeutics Market Size (2017-2028)
    7.2 Europe Rectal Cancer Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Rectal Cancer Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Rectal Cancer Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Rectal Cancer Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Rectal Cancer Therapeutics Market Size (2017-2028)
    9.2 Latin America Rectal Cancer Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Rectal Cancer Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Rectal Cancer Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Eli Lilly and Company
        11.1.1 Eli Lilly and Company Company Detail
        11.1.2 Eli Lilly and Company Business Overview
        11.1.3 Eli Lilly and Company Rectal Cancer Therapeutics Introduction
        11.1.4 Eli Lilly and Company Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.1.5 Eli Lilly and Company Recent Development
    11.2 Taiwan Liposome
        11.2.1 Taiwan Liposome Company Detail
        11.2.2 Taiwan Liposome Business Overview
        11.2.3 Taiwan Liposome Rectal Cancer Therapeutics Introduction
        11.2.4 Taiwan Liposome Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.2.5 Taiwan Liposome Recent Development
    11.3 Genentech
        11.3.1 Genentech Company Detail
        11.3.2 Genentech Business Overview
        11.3.3 Genentech Rectal Cancer Therapeutics Introduction
        11.3.4 Genentech Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.3.5 Genentech Recent Development
    11.4 Sanofi-aventis Groupe
        11.4.1 Sanofi-aventis Groupe Company Detail
        11.4.2 Sanofi-aventis Groupe Business Overview
        11.4.3 Sanofi-aventis Groupe Rectal Cancer Therapeutics Introduction
        11.4.4 Sanofi-aventis Groupe Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.4.5 Sanofi-aventis Groupe Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Rectal Cancer Therapeutics Introduction
        11.5.4 Merck Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Company Detail
        11.6.2 Bristol-Myers Squibb Business Overview
        11.6.3 Bristol-Myers Squibb Rectal Cancer Therapeutics Introduction
        11.6.4 Bristol-Myers Squibb Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.6.5 Bristol-Myers Squibb Recent Development
    11.7 Hutchison MediPharma
        11.7.1 Hutchison MediPharma Company Detail
        11.7.2 Hutchison MediPharma Business Overview
        11.7.3 Hutchison MediPharma Rectal Cancer Therapeutics Introduction
        11.7.4 Hutchison MediPharma Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.7.5 Hutchison MediPharma Recent Development
    11.8 Seattle Genetics
        11.8.1 Seattle Genetics Company Detail
        11.8.2 Seattle Genetics Business Overview
        11.8.3 Seattle Genetics Rectal Cancer Therapeutics Introduction
        11.8.4 Seattle Genetics Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.8.5 Seattle Genetics Recent Development
    11.9 Advaxis
        11.9.1 Advaxis Company Detail
        11.9.2 Advaxis Business Overview
        11.9.3 Advaxis Rectal Cancer Therapeutics Introduction
        11.9.4 Advaxis Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.9.5 Advaxis Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Detail
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Rectal Cancer Therapeutics Introduction
        11.10.4 Pfizer Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.10.5 Pfizer Recent Development
    11.11 AstraZeneca
        11.11.1 AstraZeneca Company Detail
        11.11.2 AstraZeneca Business Overview
        11.11.3 AstraZeneca Rectal Cancer Therapeutics Introduction
        11.11.4 AstraZeneca Revenue in Rectal Cancer Therapeutics Business (2017-2022)
        11.11.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Rectal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Medicine
    Table 3. Key Players of Surgery
    Table 4. Key Players of Other
    Table 5. Global Rectal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Rectal Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Rectal Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Rectal Cancer Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Rectal Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Rectal Cancer Therapeutics Market Share by Region (2023-2028)
    Table 11. Rectal Cancer Therapeutics Market Trends
    Table 12. Rectal Cancer Therapeutics Market Drivers
    Table 13. Rectal Cancer Therapeutics Market Challenges
    Table 14. Rectal Cancer Therapeutics Market Restraints
    Table 15. Global Rectal Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Rectal Cancer Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Rectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rectal Cancer Therapeutics as of 2021)
    Table 18. Ranking of Global Top Rectal Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Rectal Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Rectal Cancer Therapeutics Product Solution and Service
    Table 22. Date of Enter into Rectal Cancer Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Rectal Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Rectal Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Rectal Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Rectal Cancer Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Rectal Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Rectal Cancer Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Rectal Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Rectal Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Rectal Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Rectal Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Rectal Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Rectal Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Eli Lilly and Company Company Detail
    Table 43. Eli Lilly and Company Business Overview
    Table 44. Eli Lilly and Company Rectal Cancer Therapeutics Product
    Table 45. Eli Lilly and Company Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. Eli Lilly and Company Recent Development
    Table 47. Taiwan Liposome Company Detail
    Table 48. Taiwan Liposome Business Overview
    Table 49. Taiwan Liposome Rectal Cancer Therapeutics Product
    Table 50. Taiwan Liposome Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Taiwan Liposome Recent Development
    Table 52. Genentech Company Detail
    Table 53. Genentech Business Overview
    Table 54. Genentech Rectal Cancer Therapeutics Product
    Table 55. Genentech Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. Genentech Recent Development
    Table 57. Sanofi-aventis Groupe Company Detail
    Table 58. Sanofi-aventis Groupe Business Overview
    Table 59. Sanofi-aventis Groupe Rectal Cancer Therapeutics Product
    Table 60. Sanofi-aventis Groupe Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Sanofi-aventis Groupe Recent Development
    Table 62. Merck Company Detail
    Table 63. Merck Business Overview
    Table 64. Merck Rectal Cancer Therapeutics Product
    Table 65. Merck Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Merck Recent Development
    Table 67. Bristol-Myers Squibb Company Detail
    Table 68. Bristol-Myers Squibb Business Overview
    Table 69. Bristol-Myers Squibb Rectal Cancer Therapeutics Product
    Table 70. Bristol-Myers Squibb Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Bristol-Myers Squibb Recent Development
    Table 72. Hutchison MediPharma Company Detail
    Table 73. Hutchison MediPharma Business Overview
    Table 74. Hutchison MediPharma Rectal Cancer Therapeutics Product
    Table 75. Hutchison MediPharma Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Hutchison MediPharma Recent Development
    Table 77. Seattle Genetics Company Detail
    Table 78. Seattle Genetics Business Overview
    Table 79. Seattle Genetics Rectal Cancer Therapeutics Product
    Table 80. Seattle Genetics Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Seattle Genetics Recent Development
    Table 82. Advaxis Company Detail
    Table 83. Advaxis Business Overview
    Table 84. Advaxis Rectal Cancer Therapeutics Product
    Table 85. Advaxis Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Advaxis Recent Development
    Table 87. Pfizer Company Detail
    Table 88. Pfizer Business Overview
    Table 89. Pfizer Rectal Cancer Therapeutics Product
    Table 90. Pfizer Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Pfizer Recent Development
    Table 92. AstraZeneca Company Detail
    Table 93. AstraZeneca Business Overview
    Table 94. AstraZeneca Rectal Cancer TherapeuticsProduct
    Table 95. AstraZeneca Revenue in Rectal Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. AstraZeneca Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rectal Cancer Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Medicine Features
    Figure 3. Surgery Features
    Figure 4. Other Features
    Figure 5. Global Rectal Cancer Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Other Case Studies
    Figure 9. Rectal Cancer Therapeutics Report Years Considered
    Figure 10. Global Rectal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Rectal Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Rectal Cancer Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Rectal Cancer Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Rectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rectal Cancer Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Rectal Cancer Therapeutics Revenue in 2021
    Figure 16. North America Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Rectal Cancer Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Rectal Cancer Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Rectal Cancer Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Rectal Cancer Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Rectal Cancer Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Rectal Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Eli Lilly and Company Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 45. Taiwan Liposome Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 46. Genentech Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 47. Sanofi-aventis Groupe Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 50. Hutchison MediPharma Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 51. Seattle Genetics Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 52. Advaxis Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 53. Pfizer Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 54. AstraZeneca Revenue Growth Rate in Rectal Cancer Therapeutics Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly and Company
Taiwan Liposome
Genentech
Sanofi-aventis Groupe
Merck
Bristol-Myers Squibb
Hutchison MediPharma
Seattle Genetics
Advaxis
Pfizer
AstraZeneca
Frequently Asked Questions
Rectal Cancer Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rectal Cancer Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rectal Cancer Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports